1. Home
  2. HBI vs BLTE Comparison

HBI vs BLTE Comparison

Compare HBI & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HBI
  • BLTE
  • Stock Information
  • Founded
  • HBI 1901
  • BLTE 2018
  • Country
  • HBI United States
  • BLTE United States
  • Employees
  • HBI N/A
  • BLTE N/A
  • Industry
  • HBI Clothing/Shoe/Accessory Stores
  • BLTE Biotechnology: Pharmaceutical Preparations
  • Sector
  • HBI Consumer Discretionary
  • BLTE Health Care
  • Exchange
  • HBI Nasdaq
  • BLTE Nasdaq
  • Market Cap
  • HBI 2.4B
  • BLTE 2.1B
  • IPO Year
  • HBI 2006
  • BLTE 2022
  • Fundamental
  • Price
  • HBI $6.93
  • BLTE $77.01
  • Analyst Decision
  • HBI Buy
  • BLTE Strong Buy
  • Analyst Count
  • HBI 4
  • BLTE 4
  • Target Price
  • HBI $6.50
  • BLTE $96.00
  • AVG Volume (30 Days)
  • HBI 6.6M
  • BLTE 64.5K
  • Earning Date
  • HBI 11-06-2025
  • BLTE 11-11-2025
  • Dividend Yield
  • HBI N/A
  • BLTE N/A
  • EPS Growth
  • HBI N/A
  • BLTE N/A
  • EPS
  • HBI 0.25
  • BLTE N/A
  • Revenue
  • HBI $3,540,309,000.00
  • BLTE N/A
  • Revenue This Year
  • HBI $1.61
  • BLTE N/A
  • Revenue Next Year
  • HBI N/A
  • BLTE N/A
  • P/E Ratio
  • HBI $14.44
  • BLTE N/A
  • Revenue Growth
  • HBI 2.95
  • BLTE N/A
  • 52 Week Low
  • HBI $3.96
  • BLTE $49.00
  • 52 Week High
  • HBI $9.10
  • BLTE $86.53
  • Technical
  • Relative Strength Index (RSI)
  • HBI 74.68
  • BLTE 70.06
  • Support Level
  • HBI $6.44
  • BLTE $70.80
  • Resistance Level
  • HBI $7.05
  • BLTE $74.18
  • Average True Range (ATR)
  • HBI 0.15
  • BLTE 2.30
  • MACD
  • HBI 0.02
  • BLTE 0.71
  • Stochastic Oscillator
  • HBI 85.19
  • BLTE 83.82

About HBI Hanesbrands Inc.

Hanesbrands manufactures basic and athletic apparel under brands including Hanes, Playtex, Maidenform, Bali, Berlei, and Bonds. The company sells wholesale to discount, midmarket, and department store retailers as well as direct to consumers through stores and e-commerce. Hanesbrands is vertically integrated, as it produces nearly 75% of its products in company-controlled factories in more than three dozen nations. Hanesbrands distributes products in the Americas and Asia-Pacific. The company was founded in 1901 and is based in Winston-Salem, North Carolina. Hanesbrands has agreed to be acquired by Canadian rival Gildan.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: